Sunshine Biopharma Inc Financial Flexibility Index
Sunshine Biopharma Inc financial flexibility index. Sunshine Biopharma Inc (SBFM) has a Financial Flexibility Index of -0.15x as of June 2026. Free cash flow of $-912.85K (operating CF $-917.98K minus capex $5.13K) represents 0% of total liabilities ($6.09 Million). See free cash flow generation of Sunshine Biopharma Inc to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Sunshine Biopharma Inc (2007–2025)
Financial flexibility index of Sunshine Biopharma Inc from 2007 to 2025. Historical Financial Flexibility Index trend for Sunshine Biopharma Inc across 19 annual periods. Check how high is Sunshine Biopharma Inc's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Sunshine Biopharma Inc Financial Flexibility Index by Year (2007–2025)
Sunshine Biopharma Inc financial flexibility index by year from 2007 to 2025. Year-by-year free cash flow to debt coverage for Sunshine Biopharma Inc. For the full cash flow conversion analysis, see Sunshine Biopharma Inc cash conversion from operations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.73x | $-5.16 Million | $-5.33 Million | $7.04 Million | ▲ +49.4% |
| 2024 | -1.45x | $-10.21 Million | $-12.53 Million | $7.06 Million | ▼ -11.2% |
| 2023 | -1.30x | $-7.99 Million | $-8.78 Million | $6.14 Million | ▼ -108.4% |
| 2022 | -0.62x | $-4.94 Million | $-5.25 Million | $7.92 Million | ▲ +32.0% |
| 2021 | -0.92x | $-1.83 Million | $-1.83 Million | $1.99 Million | ▼ -180.1% |
| 2020 | -0.33x | $-656.11K | $-657.30K | $2.00 Million | ▲ +44.8% |
| 2019 | -0.59x | $-494.94K | $-495.80K | $833.53K | ▼ -44.5% |
| 2018 | -0.41x | $-493.96K | $-512.81K | $1.20 Million | ▲ +36.8% |
| 2017 | -0.65x | $-539.80K | $-543.52K | $830.85K | ▲ +42.7% |
| 2016 | -1.13x | $-310.74K | $-314.18K | $274.10K | ▼ -490.1% |
| 2015 | -0.19x | $-244.04K | $-867.64K | $1.27 Million | ▲ +80.9% |
| 2014 | -1.01x | $-533.80K | $-538.60K | $531.00K | ▲ +93.0% |
| 2013 | -14.37x | $-559.61K | $-564.40K | $38.95K | ▼ -135.3% |
| 2012 | -6.11x | $-393.05K | $-393.05K | $64.37K | ▲ +92.9% |
| 2011 | -86.58x | $-297.30K | $-297.30K | $3.43K | ▼ -183.4% |
| 2010 | -30.54x | $-348.32K | $-348.32K | $11.40K | ▼ -4175.9% |
| 2009 | -0.71x | $-10.22K | $-10.22K | $14.31K | ▲ +29.5% |
| 2008 | -1.01x | $-23.03K | $-23.03K | $22.74K | ▲ +51.3% |
| 2007 | -2.08x | $-3.12K | $-3.12K | $1.50K | — |